Control of Regulatory T Cell Lineage Commitment and Maintenance

Immunity

Volumn 30, Issue 5, 2009, Pages 616-625

  Josefowicz, Steven Z ^a,b   Rudensky, Alexander ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

CELL LINEAGE; CELL SURVIVAL; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; HUMAN; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; THYMOCYTE; TRANSCRIPTION REGULATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; PROTEIN KINASES; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 65549145814     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2009.04.009     Document Type: Review

References (107)

1. Allan S.E., Passerini L., Bacchetta R., Crellin N., Dai M., Orban P.C., Ziegler S.F., Roncarolo M.G., and Levings M.K. The role of 2 FOXP3 isoforms in the generation of human CD4+ Tregs. J. Clin. Invest. 115 (2005) 3276-3284
2. Annacker O., Coombes J.L., Malmstrom V., Uhlig H.H., Bourne T., Johansson-Lindbom B., Agace W.W., Parker C.M., and Powrie F. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J. Exp. Med. 202 (2005) 1051-1061
3. Apostolou I., Sarukhan A., Klein L., and von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3 (2002) 756-763
4. Asano M., Toda M., Sakaguchi N., and Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184 (1996) 387-396
5. Azzam H.S., DeJarnette J.B., Huang K., Emmons R., Park C.S., Sommers C.L., El-Khoury D., Shores E.W., and Love P.E. Fine tuning of TCR signaling by CD5. J. Immunol. 166 (2001) 5464-5472
6. Barnes M.J., Krebs P., Harris N., Eidenschenk C., Gonzalez-Quintial R., Arnold C.N., Crozat K., Sovath S., Moresco E.M., Theofilopoulos A.N., et al. Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery. PLoS Biol. 7 (2009) e51
7. Baron U., Floess S., Wieczorek G., Baumann K., Grutzkau A., Dong J., Thiel A., Boeld T.J., Hoffmann P., Edinger M., et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur. J. Immunol. 37 (2007) 2378-2389
8. Bautista J.L., Lio C.W., Lathrop S.K., Forbush K., Liang Y., Luo J., Rudensky A.Y., and Hsieh C.S. Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat. Immunol. (2009) 10.1038/ni.1739 in press. Published online May 10, 2009
9. Belkaid Y., and Oldenhove G. Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity 29 (2008) 362-371
10. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., Kelly T.E., Saulsbury F.T., Chance P.F., and Ochs H.D. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27 (2001) 20-21
11. Benson M.J., Pino-Lagos K., Rosemblatt M., and Noelle R.J. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 204 (2007) 1765-1774
12. Bettelli E., Korn T., Oukka M., and Kuchroo V.K. Induction and effector functions of T(H)17 cells. Nature 453 (2008) 1051-1057
13. Bonomo A., Kehn P.J., Payer E., Rizzo L., Cheever A.W., and Shevach E.M. Pathogenesis of post-thymectomy autoimmunity. Role of syngeneic MLR-reactive T cells. J. Immunol. 154 (1995) 6602-6611
14. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., Wilkinson J.E., Galas D., Ziegler S.F., and Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27 (2001) 68-73
15. Burchill M.A., Goetz C.A., Prlic M., O'Neil J.J., Harmon I.R., Bensinger S.J., Turka L.A., Brennan P., Jameson S.C., and Farrar M.A. Distinct effects of STAT5 activation on CD4+ and CD8+ T cell homeostasis: Development of CD4+CD25+ regulatory T cells versus CD8+ memory T cells. J. Immunol. 171 (2003) 5853-5864
16. Burchill M.A., Yang J., Vang K.B., and Farrar M.A. Interleukin-2 receptor signaling in regulatory T cell development and homeostasis. Immunol. Lett. 114 (2007) 1-8
17. Burchill M.A., Yang J., Vogtenhuber C., Blazar B.R., and Farrar M.A. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 178 (2007) 280-290
18. Burchill M.A., Yang J., Vang K.B., Moon J.J., Chu H.H., Lio C.W., Vegoe A.L., Hsieh C.S., Jenkins M.K., and Farrar M.A. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 28 (2008) 112-121
19. Carter J.D., Calabrese G.M., Naganuma M., and Lorenz U. Deficiency of the Src homology region 2 domain-containing phosphatase 1 (SHP-1) causes enrichment of CD4+CD25+ regulatory T cells. J. Immunol. 174 (2005) 6627-6638
20. Chatila T.A., Blaeser F., Ho N., Lederman H.M., Voulgaropoulos C., Helms C., and Bowcock A.M. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106 (2000) R75-R81
21. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., McGrady G., and Wahl S.M. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198 (2003) 1875-1886
22. Chen Z., Benoist C., and Mathis D. How defects in central tolerance impinge on a deficiency in regulatory T cells. Proc. Natl. Acad. Sci. USA 102 (2005) 14735-14740
23. Coombes J.L., Siddiqui K.R., Arancibia-Carcamo C.V., Hall J., Sun C.M., Belkaid Y., and Powrie F. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J. Exp. Med. 204 (2007) 1757-1764
24. Curotto de Lafaille M.A., Kutchukhidze N., Shen S., Ding Y., Yee H., and Lafaille J.J. Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 29 (2008) 114-126
25. Curotto de Lafaille M.A., and Lafaille J.J. Natural and adaptive Foxp3+ regulatory t cells: More of the same or a division of labor. Immunity 30 (2009) 626-635 this issue
26. Davidson T.S., DiPaolo R.J., Andersson J., and Shevach E.M. Cutting edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J. Immunol. 178 (2007) 4022-4026
27. Ehrlich P. Collected Studies on Immunity (1906), Wiley, New York
28. Elias K.M., Laurence A., Davidson T.S., Stephens G., Kanno Y., Shevach E.M., and O'Shea J.J. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood 111 (2008) 1013-1020
29. Floess S., Freyer J., Siewert C., Baron U., Olek S., Polansky J., Schlawe K., Chang H.D., Bopp T., Schmitt E., et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 5 (2007) e38
30. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4 (2003) 330-336
31. Fontenot J.D., Dooley J.L., Farr A.G., and Rudensky A.Y. Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 202 (2005) 901-906
32. Fontenot J.D., Rasmussen J.P., Gavin M.A., and Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6 (2005) 1142-1151
33. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., and Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22 (2005) 329-341
34. Gavin M.A., and Bevan M.J. Increased peptide promiscuity provides a rationale for the lack of N regions in the neonatal T cell repertoire. Immunity 3 (1995) 793-800
35. Gavin M.A., Torgerson T.R., Houston E., DeRoos P., Ho W.Y., Stray-Pedersen A., Ocheltree E.L., Greenberg P.D., Ochs H.D., and Rudensky A.Y. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc. Natl. Acad. Sci. USA 103 (2006) 6659-6664
36. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., and Rudensky A.Y. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445 (2007) 771-775
37. Germain R.N. T-cell development and the CD4-CD8 lineage decision. Nat. Rev. Immunol. 2 (2002) 309-322
38. Gupta S., Manicassamy S., Vasu C., Kumar A., Shang W., and Sun Z. Differential requirement of PKC-theta in the development and function of natural regulatory T cells. Mol. Immunol. 46 (2008) 213-224
39. Hall J.A., Bouladoux N., Sun C.M., Wohlfert E.A., Blank R.B., Zhu Q., Grigg M.E., Berzofsky J.A., and Belkaid Y. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 29 (2008) 637-649
40. Haxhinasto S., Mathis D., and Benoist C. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells. J. Exp. Med. 205 (2008) 565-574
41. Hill J.A., Hall J.A., Sun C.M., Cai Q., Ghyselinck N., Chambon P., Belkaid Y., Mathis D., and Benoist C. Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells. Immunity 29 (2008) 758-770
42. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 (2003) 1057-1061
43. Horwitz D.A., Zheng S.G., Wang J., and Gray J.D. Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ Treg. Eur. J. Immunol. 38 (2008) 912-915
44. Hsieh C.S., Liang Y., Tyznik A.J., Self S.G., Liggitt D., and Rudensky A.Y. Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors. Immunity 21 (2004) 267-277
45. Hsieh C.S., Zheng Y., Liang Y., Fontenot J.D., and Rudensky A.Y. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat. Immunol. 7 (2006) 401-410
46. Jordan M.S., Boesteanu A., Reed A.J., Petrone A.L., Holenbeck A.E., Lerman M.A., Naji A., and Caton A.J. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2 (2001) 301-306
47. Josefowicz S.Z., Wilson C.B., and Rudensky A.Y. Cutting edge: TCR stimulation is sufficient for induction of Foxp3 expression in the absence of DNA methyltransferase 1. J. Immunol. 182 (2009) in press
48. Kawahata K., Misaki Y., Yamauchi M., Tsunekawa S., Setoguchi K., Miyazaki J., and Yamamoto K. Generation of CD4(+)CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J. Immunol. 168 (2002) 4399-4405
49. Khattri R., Cox T., Yasayko S.A., and Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat. Immunol. 4 (2003) 337-342
50. Kim H.P., and Leonard W.J. CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: A role for DNA methylation. J. Exp. Med. 204 (2007) 1543-1551
51. Kim J.M., and Rudensky A. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol. Rev. 212 (2006) 86-98
52. Komatsu N., Mariotti-Ferrandiz M.E., Wang Y., Malissen B., Waldmann H., and Hori S. Heterogeneity of natural Foxp3+ T cells: A committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc. Natl. Acad. Sci. USA 106 (2009) 1903-1908
53. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M.C., and von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6 (2005) 1219-1227
54. Kretschmer K., Heng T.S., and von Boehmer H. De novo production of antigen-specific suppressor cells in vivo. Nat. Protocols 1 (2006) 653-661
55. Lathrop S.K., Santacruz N.A., Pham D., Luo J., and Hsieh C.S. Antigen-specific peripheral shaping of the natural regulatory T cell population. J. Exp. Med. 205 (2008) 3105-3117
56. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., Blank R.B., Meylan F., Siegel R., Hennighausen L., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26 (2007) 371-381
57. Li M.O., Sanjabi S., and Flavell R.A. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25 (2006) 455-471
58. Lin W., Haribhai D., Relland L.M., Truong N., Carlson M.R., Williams C.B., and Chatila T.A. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 8 (2007) 359-368
59. Lio C.W., and Hsieh C.S. A two-step process for thymic regulatory T cell development. Immunity 28 (2008) 100-111
60. Liu Y., Zhang P., Li J., Kulkarni A.B., Perruche S., and Chen W. A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat. Immunol. 9 (2008) 632-640
61. Malek T.R. The biology of interleukin-2. Annu. Rev. Immunol. 26 (2008) 453-479
62. Mantel P.Y., Ouaked N., Ruckert B., Karagiannidis C., Welz R., Blaser K., and Schmidt-Weber C.B. Molecular mechanisms underlying FOXP3 induction in human T cells. J. Immunol. 176 (2006) 3593-3602
63. Marie J.C., Letterio J.J., Gavin M., and Rudensky A.Y. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J. Exp. Med. 201 (2005) 1061-1067
64. Marie J.C., Liggitt D., and Rudensky A.Y. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 25 (2006) 441-454
65. Maynard C.L., Hatton R.D., Helms W.S., Oliver J.R., Stephensen C.B., and Weaver C.T. Contrasting roles for all-trans retinoic acid in TGF-beta-mediated induction of Foxp3 and Il10 genes in developing regulatory T cells. J. Exp. Med. 206 (2009) 343-357
66. Medoff B.D., Sandall B.P., Landry A., Nagahama K., Mizoguchi A., Luster A.D., and Xavier R.J. Differential requirement for CARMA1 in agonist-selected T-cell development. Eur. J. Immunol. 39 (2009) 78-84
67. Molinero L.L., Yang J., Gajewski T., Abraham C., Farrar M.A., and Alegre M. CARMA1 controls an early checkpoint in the thymic development of FoxP3+ regulatory T cells. J. Immunol. 182 (2009) in press
68. Morgan M.E., van Bilsen J.H., Bakker A.M., Heemskerk B., Schilham M.W., Hartgers F.C., Elferink B.G., van der Zanden L., de Vries R.R., Huizinga T.W., et al. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum. Immunol. 66 (2005) 13-20
69. Nishizuka Y., and Sakakura T. Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166 (1969) 753-755
70. Ohki H., Martin C., Corbel C., Coltey M., and Le Douarin N.M. Tolerance induced by thymic epithelial grafts in birds. Science 237 (1987) 1032-1035
71. Olivares-Villagomez D., Wang Y., and Lafaille J.J. Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J. Exp. Med. 188 (1998) 1883-1894
72. Pacholczyk R., and Kern J. The T-cell receptor repertoire of regulatory T cells. Immunology 125 (2008) 450-458
73. Pacholczyk R., Ignatowicz H., Kraj P., and Ignatowicz L. Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells. Immunity 25 (2006) 249-259
74. Polansky J.K., Kretschmer K., Freyer J., Floess S., Garbe A., Baron U., Olek S., Hamann A., von Boehmer H., and Huehn J. DNA methylation controls Foxp3 gene expression. Eur. J. Immunol. 38 (2008) 1654-1663
75. Sakaguchi S., Takahashi T., and Nishizuka Y. Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J. Exp. Med. 156 (1982) 1565-1576
76. Sakaguchi S., Sakaguchi N., Asano M., Itoh M., and Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155 (1995) 1151-1164
77. Salomon B., Lenschow D.J., Rhee L., Ashourian N., Singh B., Sharpe A., and Bluestone J.A. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12 (2000) 431-440
78. Sauer S., Bruno L., Hertweck A., Finlay D., Leleu M., Spivakov M., Knight Z.A., Cobb B.S., Cantrell D., O'Connor E., et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. USA 105 (2008) 7797-7802
79. Schmidt-Supprian M., Tian J., Grant E.P., Pasparakis M., Maehr R., Ovaa H., Ploegh H.L., Coyle A.J., and Rajewsky K. Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc. Natl. Acad. Sci. USA 101 (2004) 4566-4571
80. Selvaraj R.K., and Geiger T.L. A kinetic and dynamic analysis of Foxp3 induced in T cells by TGF-beta. J. Immunol. 179 (2007) 1390-1401
81. Shevach E.M., Tran D.Q., Davidson T.S., and Andersson J. The critical contribution of TGF-beta to the induction of Foxp3 expression and regulatory T cell function. Eur. J. Immunol. 38 (2008) 915-917
82. Shevach E.M. Mechanisms of Foxp3+ T regulatory cell-mediated suppression. Immunity 30 (2009) 636-645 this issue
83. Singer A., Adoro S., and Park J.H. Lineage fate and intense debate: Myths, models and mechanisms of CD4- versus CD8-lineage choice. Nat. Rev. Immunol. 8 (2008) 788-801
84. So T., and Croft M. Cutting edge: OX40 inhibits TGF-beta- and antigen-driven conversion of naive CD4 T cells into CD25+Foxp3+ T cells. J. Immunol. 179 (2007) 1427-1430
85. Sriskantharajah S., Belich M.P., Papoutsopoulou S., Janzen J., Tybulewicz V., Seddon B., and Ley S.C. Proteolysis of NF-kappaB1 p105 is essential for T cell antigen receptor-induced proliferation. Nat. Immunol. 10 (2009) 38-47
86. Sun C.M., Hall J.A., Blank R.B., Bouladoux N., Oukka M., Mora J.R., and Belkaid Y. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 204 (2007) 1775-1785
87. Tai X., Cowan M., Feigenbaum L., and Singer A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 6 (2005) 152-162
88. Tone Y., Furuuchi K., Kojima Y., Tykocinski M.L., Greene M.I., and Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 9 (2008) 194-202
89. Tran D.Q., Ramsey H., and Shevach E.M. Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 110 (2007) 2983-2990
90. van Santen H.M., Benoist C., and Mathis D. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J. Exp. Med. 200 (2004) 1221-1230
91. Vang K.B., Yang J., Mahmud S.A., Burchill M.A., Vegoe A.L., and Farrar M.A. IL-2, -7, and -15, but not thymic stromal lymphopoeitin, redundantly govern CD4+Foxp3+ regulatory T cell development. J. Immunol. 181 (2008) 3285-3290
92. Vu M.D., Xiao X., Gao W., Degauque N., Chen M., Kroemer A., Killeen N., Ishii N., and Chang Li X. OX40 costimulation turns off Foxp3+ Tregs. Blood 110 (2007) 2501-2510
93. Walker L.S., Chodos A., Eggena M., Dooms H., and Abbas A.K. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J. Exp. Med. 198 (2003) 249-258
94. Wan Y.Y., and Flavell R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445 (2007) 766-770
95. Wang J., Ioan-Facsinay A., van der Voort E.I., Huizinga T.W., and Toes R.E. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur. J. Immunol. 37 (2007) 129-138
96. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., Levy-Lahad E., Mazzella M., Goulet O., Perroni L., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27 (2001) 18-20
97. Williams L.M., and Rudensky A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8 (2007) 277-284
98. Wong P., Barton G.M., Forbush K.A., and Rudensky A.Y. Dynamic tuning of T cell reactivity by self-peptide-major histocompatibility complex ligands. J. Exp. Med. 193 (2001) 1179-1187
99. Wong J., Mathis D., and Benoist C. TCR-based lineage tracing: no evidence for conversion of conventional into regulatory T cells in response to a natural self-antigen in pancreatic islets. J. Exp. Med. 204 (2007) 2039-2045
100. Wong J., Obst R., Correia-Neves M., Losyev G., Mathis D., and Benoist C. Adaptation of TCR repertoires to self-peptides in regulatory and nonregulatory CD4+ T cells. J. Immunol. 178 (2007) 7032-7041
101. Xiao S., Jin H., Korn T., Liu S.M., Oukka M., Lim B., and Kuchroo V.K. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J. Immunol. 181 (2008) 2277-2284
102. Yao Z., Kanno Y., Kerenyi M., Stephens G., Durant L., Watford W.T., Laurence A., Robinson G.W., Shevach E.M., Moriggl R., et al. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 109 (2007) 4368-4375
103. Zheng S.G., Wang J.H., Gray J.D., Soucier H., and Horwitz D.A. Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J. Immunol. 172 (2004) 5213-5221
104. Zheng S.G., Wang J.H., Stohl W., Kim K.S., Gray J.D., and Horwitz D.A. TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells. J. Immunol. 176 (2006) 3321-3329
105. Zhu J., Davidson T.S., Wei G., Jankovic D., Cui K., Schones D.E., Guo L., Zhao K., Shevach E.M., and Paul W.E. Down-regulation of Gfi-1 expression by TGF-{beta} is important for differentiation of Th17 and CD103+ inducible regulatory T cells. J. Exp. Med. 206 (2009) 329-341
106. Ziegler S.F. FOXP3: of mice and men. Annu. Rev. Immunol. 24 (2006) 209-226
107. Zhou L., Chong M.M.W., and Littman D.R. Plasticity of CD4+ T cell lineage differentiation. Immunity 30 (2009) 646-655 this issue